SNT - Research & Valuation, page-5

  1. 7,851 Posts.
    lightbulb Created with Sketch. 647

    ma420 FYI in case you don't know already...

    1. MST is a Syntara/Pharmaxis PAID analyst who has been written super-upbeat report for PXS for over 5 years.
    2. MST has always given PXS target price of over 30 cents, even when it was trading at way below 5 cents.

    Don't get me wrong Ma420 I don't mean to pour cold water or spoil the party or something like that ... just be careful with them and take it with a grain of salt.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.